|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-2-9
|
|
pubmed:abstractText |
In ST-segment elevation myocardial infarction (STEMI) treated with fibrin-specific thrombolytic agents, early intravenous unfractionated heparin (UFH) is warranted. Low molecular weight heparin Enoxaparin currently represents an alternative to UFH, to be used until hospital discharge. Since optimal dosing of subcutaneous Enoxaparin is not standardized, we conducted an observational study to compare safety and efficacy of low (4,000 U once daily) vs full dose (100 U/kg twice daily) regimens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0026-4725
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
131-7
|
|
pubmed:meshHeading |
pubmed-meshheading:16467747-Aged,
pubmed-meshheading:16467747-Dose-Response Relationship, Drug,
pubmed-meshheading:16467747-Drug Therapy, Combination,
pubmed-meshheading:16467747-Enoxaparin,
pubmed-meshheading:16467747-Female,
pubmed-meshheading:16467747-Fibrinolytic Agents,
pubmed-meshheading:16467747-Heart Conduction System,
pubmed-meshheading:16467747-Heparin,
pubmed-meshheading:16467747-Humans,
pubmed-meshheading:16467747-Injections, Intravenous,
pubmed-meshheading:16467747-Injections, Subcutaneous,
pubmed-meshheading:16467747-Italy,
pubmed-meshheading:16467747-Male,
pubmed-meshheading:16467747-Middle Aged,
pubmed-meshheading:16467747-Myocardial Infarction,
pubmed-meshheading:16467747-Prospective Studies,
pubmed-meshheading:16467747-Thrombolytic Therapy,
pubmed-meshheading:16467747-Tissue Plasminogen Activator,
pubmed-meshheading:16467747-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose.
|
|
pubmed:affiliation |
Division of Cardiology, Ospedale Maggiore, Bologna, Italy. andrearubboli@libero.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
